Evidence map›Paper›PMID 36674306›Full record

ArticleInternational journal of environmental research and public health2023

Creation and Validation of a Portuguese Version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.

Pedro L Ferreira, Inês Genrinho, Tânia Santiago, Adriana Carones, Carolina Mazeda, Anabela Barcelos, Tiago Beirão, Flávio Costa, Inês Santos, Maura Couto and 3 more

Abstract readMulticenter Study
In one paragraph

Article in International journal of environmental research and public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Validation of the Portuguese Version of the Scleroderma Health Assessment Questionnaire.International journal of environmental research and public health · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Pedro L FerreiraCentre for Health Studies and Research, Faculty of Economics, University of Coimbra, 3004-512 Coimbra, Portugal.ORCID 0000-0002-9448-9542
Inês GenrinhoRheumatology Department, Tondela Viseu Hospital Centre, 3504-509 Viseu, Portugal.ORCID 0000-0003-1159-0491
Tânia SantiagoRheumatology Department, Coimbra and University Health Center, 3004-512 Coimbra, Portugal.ORCID 0000-0002-1562-4022
Adriana CaronesRheumatology Department, Coimbra and University Health Center, 3004-512 Coimbra, Portugal.
Carolina MazedaBaixo Vouga Hospital Centre, Rheumatology Department, Egas Moniz Health Alliance, 3810-164 Aveiro, Portugal.
Anabela BarcelosBaixo Vouga Hospital Centre, Rheumatology Department, Egas Moniz Health Alliance, 3810-164 Aveiro, Portugal.ORCID 0000-0002-4116-8964
Tiago BeirãoRheumatology Department, Vila Nova de Gaia/Espinho Hospital Centre, 4434-502 Vila Nova de Gaia, Portugal.
Flávio CostaRheumatology Department, Vila Nova de Gaia/Espinho Hospital Centre, 4434-502 Vila Nova de Gaia, Portugal.ORCID 0000-0002-8231-7110
Inês SantosRheumatology Department, Tondela Viseu Hospital Centre Hospital Centre, 3460-525 Tondela, Portugal.
Maura CoutoRheumatology Department, Tondela Viseu Hospital Centre Hospital Centre, 3460-525 Tondela, Portugal.
Maria RatoRheumatology Department, São João University Hospital Centre Hospital Centre, 4200-319 Porto, Portugal.
Georgina TerrosoRheumatology Department, São João University Hospital Centre Hospital Centre, 4200-319 Porto, Portugal.
Paulo MonteiroRheumatology Department, Tondela Viseu Hospital Centre Hospital Centre, 3460-525 Tondela, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: The UCLA GIT 2.0 questionnaire has been recognized as a feasible and reliable instrument to assess gastrointestinal (GI) symptoms in systemic sclerosis (SSc) patients and their impact on quality of life. The aim of this study was to create and validate UCLA GIT 2.0 for Portuguese patients with SSc. (2) Methods: A multi-center study was conducted enrolling SSc patients. UCLA GIT 2.0 was validated in Portuguese using reliability (internal consistency, item -total correlation, and reproducibility) and validity (content, construct, and criterion) tests. Criterion tests included EQ-5D and SF-36v2. Social-demographic and clinical data were collected. (3) Results: 102 SSc patients were included, 82.4% of them female, and with a mean sample age of 57.0 ± 12.5 years old. The limited form of SSc was present in 62% of the patients and 56.9% had fewer than five years of disease duration. Almost 60% presented with SSc-GI involvement with a negative impact on quality of life. The means for SF-36v2 were 39.3 ± 10.3 in the physical component summary and 47.5 ± 12.1 in the mental component summary. Total GI score, reported as mild in 57.8% of the patients, was highly reliable (ICC = 0.912) and the Cronbach's alpha was 0.954. There was a high correlation between the total GI score and EQ-5D-5L and SF-36v2 scores. (4) Conclusion: The Portuguese version of UCLA GIT 2.0 showed good psychometric properties and can be used in research and clinical practice.

Indexed as

Gastrointestinal DiseasesScleroderma, SystemicAdultAgedFemaleHumansMiddle AgedPortugalPsychometricsQuality of LifeReproducibility of ResultsSeverity of Illness IndexSurveys and Questionnairesgastrointestinal tractquality of lifesystemic sclerosisUCLA GIT 2.0

Identifiers

PMID36674306
PMCPMC9865185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.